In terms of ME of tumors, the present study determined that ME was heterogeneously distributed in different glioma individuals, which is related to tumor grade and MGMT methylation, IDH mutation, and 1p/19q co-deletion status. This evidence concerns the gene IDH1 and central nervous system cancer.